Craig C. Hopkinson - EVP R&D, Chief Medical Officer at Alkermes plc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP R&D, Chief Medical Officer
Stock Symbol
ALKS, ALKSV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Craig C. Hopkinson since 7/7/2023

Holdings reported by Craig C. Hopkinson for Alkermes plc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Ordinary Shares 109,709 $3.24 M $29.57 Feb 23, 2024 Direct
Employee Stock Option (Right to Buy) 111,186 $2.98 M $26.82 Feb 26, 2024 Direct Ordinary Shares
Restricted Stock Unit Award 27,464 Feb 26, 2024 Direct Ordinary Shares

Transactions reported by Craig C. Hopkinson for Alkermes plc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership